F18-FLT PET/CT as a Tool for Assessment of Myeloablative Treatment in Patients With Acute Myeloid Leucemia(AML)

NCT01592266 · clinicaltrials.gov ↗
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Hadassah Medical Organization